Spinal Cord Injury
Overview
Spinal cord injury (SCI) is defined as damage or trauma
caused to the spinal cord. SCI can lead to loss or impaired function resulting
in reduced mobility or feeling. It is usually caused by trauma, transverse
myelitis, polio, spina bifida or Friedreich's ataxia. Signs and symptoms of
spinal cord injury include extreme back pain or pressure in the neck, head or
back, paralysis in any part of the body, numbness, tingling or loss of
sensation in the hands, fingers, feet or toes, loss of bladder or bowel
control, difficulty in walking and impaired breathing after injury.
Click here for sample
report @ http://www.wiseguyreports.com/sample-request/1306957-spinal-cord-injury-pipeline-review-h1-2017
Spinal Cord Injury Industry Major
Outlook
The Pharmaceutical and Healthcare latest pipeline guide
Spinal Cord Injury - Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Spinal Cord Injury
(Central Nervous System), complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and
press releases.
The Spinal Cord Injury (Central Nervous System) pipeline
guide also reviews of key players involved in therapeutic development for
Spinal Cord Injury and features dormant and discontinued projects. The guide
covers therapeutics under Development by Companies /Universities /Institutes,
the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA
Filed, Preclinical and Discovery stages are 2, 6, 8, 1, 24 and 6 respectively.
Similarly, the Universities portfolio in Phase I, Preclinical and Discovery
stages comprises 1, 14 and 2 molecules, respectively.
Spinal Cord Injury (Central Nervous System) pipeline guide
helps in identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a
real time basis.
Spinal Cord Injury -
Competitive Analysis
Key players are making innovative
developments in Spinal Cord Injury industry. The same will help in improving the market
performance. Heavy investments are made by major players in the R&D sector
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Spinal Cord Injury (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Spinal Cord Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Spinal Cord Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Spinal Cord Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Spinal Cord Injury (Central Nervous System)
- The pipeline guide reviews pipeline therapeutics for Spinal Cord Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Spinal Cord Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Spinal Cord Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Spinal Cord Injury (Central Nervous System)
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1306957-spinal-cord-injury-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. Wise Guy Reports understand how essential statistical surveying
information is for your organization or association. Therefore, we have
associated with the top publishers and research firms all specialized in
specific domains, ensuring you will receive the most reliable and up to date
research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment